Minireviews
Copyright ©The Author(s) 2020.
World J Gastroenterol. Mar 28, 2020; 26(12): 1273-1285
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1273
Table 1 Genes and their single nucleotide polymorphisms investigated in association with acute cellular rejection after liver transplantation
Ref.Etiology/Population
Genes and best 95%CI ORKey points
N (non-ACR/ACR)
Yu et al[13]VariousRecipient CD276: rs2127015 (0.05-0.93); NS for: rs11072431, rs11574495, rs12593558, rs12594627, rs3816661 rs7176654; Recipient TREML2: rs4714431, rs6915083, rs7754593, rs9394767 NS1Recipient's CD276 (rs2127015) T allele is weakly associated with ACR and with CD276 mRNA expression
Eastern Asian
334/54
Ostojic et al[14]AlcoholicRecipient CXCL9: rs10336 NS; Recipient CXCL10: rs3921 NSNo association found. CXCL9 (rs10336) is associated with earlier ACR occurrence and higher plasma CXCL9 concentrations
European
156/59
Sun et al[12]VariousRecipient IL-17: rs2275913 (0.07-0.77)2Associated with increased IL-17 plasma concentration and with cyclosporine metabolism (CYP3A4 and CYP3A5 expression)
Eastern Asian
66/40
Verma et al[16]VariousRecipient FOXP3: rs3761547, rs3761548, and rs2232365 NSAssociation found only in a very small subgroup of steroid resistant ACR patients (N = 5) for rs3761548
Asian
86/16
Associated with the degree of mixed lymphocyte reaction
Thude et al[15]VariousRecipient KLRB1: rs1135816 NSNo association found
European
163/178
Thude et al[8]VariousRecipient HPA-3 a/b: rs5910 (1.749–41.8); Recipient/donor incompatibility: rs5910 (1.78–7.39); HPA-1, -2, -3, -5, -15 NS for allHPA-3 incompatibility and HPA-3 b/b genotype were associated with higher incidence of ACR
European
53/43
There was no difference in the time of ACR occurrence
Fereidooni et al[10]VariousRecipient IL28B: rs12979860 NSNo association found
Western Asian
101/39
Valero-Hervás et al[11]VariousRecipient C3 complement rs2230199 (0.09-0.77)C3FF genotype is associated with lower incidence of ACR, independently after multivariate analysis for sex, HCV infection, therapy and donor type
European
277/185